Advertisement
Mayo Clinic Proceedings Home

Transurethral Enzyme Injection—Future Management of Benign Prostatic Hyperplasia

      Although benign prostatic hyperplasia, a common condition among elderly men, has been effectively treated with transurethral resection of the prostate, this surgical procedure is associated with many well-recognized risks and complications. Because of this potential morbidity and mortality, various alternative treatment strategies for benign prostatic hyperplasia have been proposed. The use of enzyme solubilization and ablation of prostatic tissue to alleviate urinary outlet obstruction has proved effective in dogs and warrants investigation in human trials. Transurethral enzyme injection of the prostate has the potential for being a treatment modality with minimal invasiveness, limited requirements for anesthesia, and minimal associated toxicity for the management of benign prostatic hyperplasia.
      PH (benign prostatic hyperplasia), TURP (transurethral resection of the prostate)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Mayo Clinic Proceedings
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Mebust WK
        • Holtgrewe HL
        • Cockett AT
        • Peters PC
        Transurethral prostatectomy: immediate and postoperative complications: a cooperative study of 13 participating institutions evaluating 3,885 patients.
        J Urol. 1989; 141: 243-247
      1. Gokcen M, Guy TJ, Inventors. Immunolytics, Inc., assignee. Method for treating benign prostatic hypertrophy. US patent 5.116,615. 1992 May 26

        • Longo FW
        • Ehrich R
        • Lattimer JK
        Collagenase as an adjunct to cryoprostatectomy.
        in: Mandl I Collagenase. Gordon and Breach Science Publishers, New York1972: 113-120
        • Woessner Jr, JF
        Matrix metalloproteinases and their inhibitors in connective tissue remodeling.
        FASEB J. 1991; 5: 2145-2154
        • Harmon WJ
        • Barrett DM
        • Qian J
        • Lauvetz RW
        • Bostwlck DG
        • Gokcen M
        Transurethral enzymatic ablation of the prostate: canine model.
        Urology. 1996; 48: 229-233